Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Zoetis Belgium SA
EIR
•Zoetis Belgium SA•September 28, 2021

Zoetis Belgium SA – FDA EIR, Sep 28, 2021

Record Details

An FDA pre-approval inspection was conducted at Zoetis Belgium SA in Tullamore, County Offaly, Ireland, from September 20 to September 28, 2021. The inspection's primary objective was to assess the facility's readiness and adherence to Current Good Manufacturing Practices (cGMP) for its new animal drug application (NADA N-141546-A-0000) concerning frunevetmab, an anti-nerve growth factor monoclonal antibody drug substance for veterinary use. The regulatory framework for this assessment included requirements under 21 CFR Parts 210 and 211, 21 CFR Part 314, and the Federal Food, Drug and Cosmetic Act, specifically guided by the Pre-Approval Inspection for New Animal Drug Application (CPGM 7368.001). The inspection comprehensively reviewed various operational aspects, including quality unit responsibilities, process deviations, out-of-specification investigations, personnel training and qualifications, equipment maintenance, facility controls, laboratory operations, production records, supplier qualifications, and stability data. Emphasis was placed on controls associated with critical manufacturing processes and the integrity of related documentation. Notably, the inspection concluded without disclosing any significant cGMP deficiencies, resulting in no issuance of an FDA Form 483 (Inspectional Observations). As a post-inspection commitment, Zoetis Belgium SA agreed to perform specific analytical tests on each batch of frunevetmab drug substance.

Company
Zoetis Belgium SA
Inspection date
September 28, 2021
Product type
Veterinary
Office
Center for Drug Evaluation and Research
People
  • Chris Beltz (company_representative)
  • Deidre Corcoran (company_representative)
  • Stephanie Ryan (company_representative)
  • Frank Bracken (company_representative)
  • Jose E. Melendez (Quality System Specialist)
View Company Profile

ID · 2c5d1500-a520-4966-b1e8-47a824797482

Violation Codes4
21 CFR 21121 CFR 21021 CFR 31421 CFR 820.50

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Zoetis Belgium SA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.